Jelena Aleksic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration

Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSoult ukpyolsiSouth koreaShinichiro nishishitaSosei heptaresGemma mosesSosei heptareErica hollingsworthMatt barnesKentaro taharaMaya bennisonJelena aleksicFrazer hallMedistrava consulting for international mediaTokyo stock exchange

PharmEnable announces multi-target collaboration with Denali Therapeutics in neurodegenerative disease

/PRNewswire/ PharmEnable, an AI drug-discovery company mapping unexplored chemical space to deliver innovative medicines, has announced a collaboration with.

United kingdomAlexander schuthPrnewswire pharmenableCarme montJelena aleksicDenali therapeuticsChief operatingFinancial officerHealth care amp hospitalsMedical pharmaceuticals

PharmEnable announces multi-target collaboration with Denali Therapeutics in neurodegenerative disease

In this collaboration, PharmEnable will leverage its proprietary AI drug discovery platform with Denali’s expertise in delivery across the BBB and neurodegeneration to identify therapeutically relevant small molecule chemical matter against challenging targets.

United kingdomAlexander schuthCarme montJelena aleksicDenali therapeuticsChief operatingFinancial officerHarmenable announces multi target collaboration with denali therapeutics in neurodegenerative disease

Introducing a new family favourite: the Rowntree s Ocean Adventure Ice Lolly – Retail Times

Introducing a new family favourite: the Rowntree s Ocean Adventure Ice Lolly – Retail Times
retailtimes.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from retailtimes.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomJelena aleksicOcean adventureTotal coverageFruit pastillesFruit stackHappy thinking

Sosei Heptares and PharmEnable Enter Technology Collaboration for AI-driven Drug Discovery against Challenging GPCR Target

Share this article Share this article TOKYO and CAMBRIDGE, England, Jan. 12, 2021 /PRNewswire/ Sosei Group Corporation ( the Company ) (TSE: 4565) and PharmEnable, a UK drug discovery company, announce they have entered a collaboration to apply their respective technologies to drive novel drug discovery against a challenging G protein-couple receptor (GPCR) target associated with neurological diseases. The collaboration will combine Sosei Heptares world-leading GPCR-focused structure-based drug design platform, which has fully structurally enabled the GPCR target, providing detailed structural insights and an assessment of tractability, with PharmEnable s proprietary advanced artificial intelligence (AI)-enabled and medicinal chemistry technologies (ChemUniverse and ChemSeek) to identify novel, highly specific drug leads for further development.

United kingdomSosei heptaresHironoshin nomuraSue charlesGenentech rocheCitigate dewe rogersonSosei heptareJelena aleksicShinichiro nishishitaSosei group corporationInternational mediaGroup corporation the companyUniversity of cambridgeSosei groupTokyo stock exchangeGroup corporation